アブレーション技術の世界市場：市場規模・シェア分析 (製品別・用途別・エンドユーザー別)、産業需要の予測 (～2030年)

世界のアブレーション技術市場は、2023年に53億1,320万米ドルの収益を達成し、2024年から2030年まで9.0%のCAGRで成長すると予測されています。この成長により、2030年の市場規模は96億7,290万米ドルに達すると予想されます。

この発展の背景には、心臓病、がん、眼科、婦人科、泌尿器科疾患などの慢性疾患の患者数の急増があります。その結果、効率的な外科的治療の必要性が高まり、アブレーションデバイスの需要が高まっています。

高周波アブレーターが市場を独占

高周波アブレーターセグメントは、2023年に25%と最大のシェアを占めました。また、予測期間中のCAGRは9.2%と予測されています。

このカテゴリーが成長しているのは、良性腫瘍や腫瘍性腫瘍、慢性的な首や背中の痛み、足の慢性的な静脈欠乏症など、いくつかの治療にRFAが利用されるようになってきているためです。

アブレーション技術は心血管治療で最も多く使用されている

心臓血管カテゴリーは、2023年に用途の点で最大のシェアを占めました。

アブレーション技術は心房細動の治療に広く使用されており、不規則な心拍の原因となる不規則な電気信号を破壊するのに役立っています。

北米が市場で最大のシェアを占める

2023年、北米地域はアブレーション技術産業で最大の市場でした。これは、この技術の成長と多くの治療への応用に関する知識の増加によるものです。

予測期間中、アジア太平洋は9.5%のCAGRで最も急速に成長します。これは、低侵襲的方法に関する知識の急増、医療制度の発展、経済成長によるものです。

当レポートでは、世界のアブレーション技術の市場について分析し、市場の基本構造・最新情勢や主な促進・抑制要因、世界全体および地域別・主要国の市場規模の動向見通し (金額ベース、2017～2030年)、製品別・用途別・エンドユーザー別の詳細動向、現在の市場競争の状況、主要企業のプロファイルなどを調査しております。

目次

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場指標

第5章 業界の展望

• 市場力学
  • 動向
  • 促進要因
  • 抑制要因/課題
  • 促進要因/抑制要因の影響分析
• 新型コロナウイルス感染症 (COVID-19) の影響
• ポーターのファイブフォース分析

第6章 世界市場

• 概要
• 市場収益：製品別 (2017～2030年)
• 市場収益：用途別 (2017～2030年)
• 市場収益：エンドユーザー別 (2017～2030年)
• 市場収益：地域別 (2017～2030年)

第7章 北米市場

• 概要
• 市場収益：製品別 (2017～2030年)
• 市場収益：用途別 (2017～2030年)
• 市場収益：エンドユーザー別 (2017～2030年)
• 市場収益：国別 (2017～2030年)

第8章 欧州市場

第9章 アジア太平洋市場

第10章 ラテンアメリカ市場

第11章 中東・アフリカ (MEA) 市場

第12章 米国市場

• 概要
• 市場収益：製品別 (2017～2030年)
• 市場収益：用途別 (2017～2030年)
• 市場収益：エンドユーザー別 (2017～2030年)

第13章 カナダ市場

第14章 ドイツ市場

第15章 フランス市場

第16章 英国市場

第17章 イタリア市場

第18章 スペイン市場

第19章 日本市場

第20章 中国市場

第21章 インド市場

第22章 オーストラリア市場

第23章 韓国市場

第24章 ブラジル市場

第25章 メキシコ市場

第26章 サウジアラビア市場

第27章 南アフリカ市場

第28章 アラブ首長国連邦 (UAE) 市場

第29章 競合情勢

• 市場参入企業とその提供製品/サービスの一覧
• 主要企業の競合ベンチマーク
• 主要企業の製品ベンチマーク
• 最近の戦略展開状況

第30章 企業プロファイル

• Medtronic plc.
• Johnson & Johnson Services Inc.
• Abbott Laboratories
• Boston Scientific Corporation
• Olympus Corporation
• Stryker Corporation
• Smith & Nephew plc
• Varian Medical Systems Inc.
• CONMED Corporation
• AngioDynamics Inc.

第31章 付録

The ablation technology market worldwide achieved revenue of USD 5,313.2 million in

2023, and it is anticipated to grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2030. This growth is expected to lead to a market size of USD 9,672.9 million by the year 2030.

The development can be credited to the surge in the count of cases of chronic diseases, like heart diseases, cancer, and ophthalmologic, gynecological, and urological diseases. As a result, there is an increased need for efficient surgical treatments, leading to higher demand for ablation devices.

Market Trends/Drivers

The increasing awareness regarding ablation procedures, growing healthcare spending, growing count of cancer cases, less cost of this procedure, and technical enhancements in related devices are the key reasons boosting the industry.

The growing count of hospitals and ambulatory operation centers is projected to fuel the development of the industry.

The growth in the ageing populace and surge in the need for minimally invasive procedures, credited to their benefits over the conventional, open procedures, will boost the product need.

Furthermore, minimally invasive methods provide precise results and are inexpensive for both care patients and providers. Moreover, the range of these procedures obtainable for different parts of the body, like brain surgeries, adrenalectomies, hiatal hernia repairs, colectomies, and nephrectomies, has made them enormously popular.

The Market Is Dominated by Radiofrequency Ablators

The radiofrequency ablators segment held the largest share, 25%, in 2023.

It is projected to experience a CAGR of 9.2% during the projection period.

This category is growing because of the growing utilization of RFA for several treatments like benign and oncogenic tumors, chronic neck and back pain, chronic venous deficiency in the legs, and more.

RFA is also used for treating atrial fibrillation, an irregular heartbeat condition.

FDA approvals for advanced radiofrequency ablators are expected to further boost the market.

Example: RF Medical Co. Ltd. received FDA clearance in December 2022 for its MYGEN M-3004 generator and MYOBLATE RFA system for use in the U.S.

Laser ablation also grips a substantial share in the industry, because of the research being done on this technology. In their January 2023 study, researchers showed that the co-administration of compression therapy with endovenous laser ablation positively impacted the rate of healing of venous ulcers and reduced the likelihood of recurrence.

Ablation Technology Founds Its Highest Usage in Cardiovascular Treatments

The cardiovascular category held the largest share in 2023 in terms of application.

Ablation technology is extensively used in treating atrial fibrillation, aiding in disrupting the irregular electrical signals responsible for irregular heartbeats.

Each cell in the myocardium generates its own signal for heartbeat, and when synchronization fails among cells, arrhythmia (irregular heartbeat) can result.

Ablation procedures are utilized to block the aberrant electric signals causing arrhythmias, restoring normal heart rhythm.

North America Held the Largest Share in the Market

In 2023, the North American region was the largest customer in the ablation technology industry, because of the growth in the technology and increasing knowledge about its applications in many treatments.

The surge in the count of patients who are suffering from chronic diseases mainly cancer is contributing to the development of the industry. Already, cancer is one of the top 10 foremost causes of demise in the nation. Its death rate is projected to surge to approximately 3 million by the end of 2040. also, approximately 37.3 million individuals in the nation were found to have diabetes, and about 96 million grownups were found to have pre-diabetes.

During the projection period, the Asia-Pacific region will be the fastest-rising ablation tech industry, with a CAGR of 9.5%. This can be credited to the surging knowledge regarding minimally invasive methods, growing healthcare systems, and rising economies.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by application
  • 1.4.3. Market size breakdown, by end user
  • 1.4.4. Market size breakdown, by region
  • 1.4.5. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Product (2017-2030)
• 6.3. Market Revenue, by Application (2017-2030)
• 6.4. Market Revenue, by End User (2017-2030)
• 6.5. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Product (2017-2030)
• 7.3. Market Revenue, by Application (2017-2030)
• 7.4. Market Revenue, by End User (2017-2030)
• 7.5. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Product (2017-2030)
• 8.3. Market Revenue, by Application (2017-2030)
• 8.4. Market Revenue, by End User (2017-2030)
• 8.5. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Product (2017-2030)
• 9.3. Market Revenue, by Application (2017-2030)
• 9.4. Market Revenue, by End User (2017-2030)
• 9.5. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Product (2017-2030)
• 10.3. Market Revenue, by Application (2017-2030)
• 10.4. Market Revenue, by End User (2017-2030)
• 10.5. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Product (2017-2030)
• 11.3. Market Revenue, by Application (2017-2030)
• 11.4. Market Revenue, by End User (2017-2030)
• 11.5. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Product (2017-2030)
• 12.3. Market Revenue, by Application (2017-2030)
• 12.4. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Product (2017-2030)
• 13.3. Market Revenue, by Application (2017-2030)
• 13.4. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Product (2017-2030)
• 14.3. Market Revenue, by Application (2017-2030)
• 14.4. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Product (2017-2030)
• 15.3. Market Revenue, by Application (2017-2030)
• 15.4. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Product (2017-2030)
• 16.3. Market Revenue, by Application (2017-2030)
• 16.4. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Product (2017-2030)
• 17.3. Market Revenue, by Application (2017-2030)
• 17.4. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Product (2017-2030)
• 18.3. Market Revenue, by Application (2017-2030)
• 18.4. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Product (2017-2030)
• 19.3. Market Revenue, by Application (2017-2030)
• 19.4. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Product (2017-2030)
• 20.3. Market Revenue, by Application (2017-2030)
• 20.4. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Product (2017-2030)
• 21.3. Market Revenue, by Application (2017-2030)
• 21.4. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Product (2017-2030)
• 22.3. Market Revenue, by Application (2017-2030)
• 22.4. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Product (2017-2030)
• 23.3. Market Revenue, by Application (2017-2030)
• 23.4. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Product (2017-2030)
• 24.3. Market Revenue, by Application (2017-2030)
• 24.4. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Product (2017-2030)
• 25.3. Market Revenue, by Application (2017-2030)
• 25.4. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Product (2017-2030)
• 26.3. Market Revenue, by Application (2017-2030)
• 26.4. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Product (2017-2030)
• 27.3. Market Revenue, by Application (2017-2030)
• 27.4. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Product (2017-2030)
• 28.3. Market Revenue, by Application (2017-2030)
• 28.4. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Medtronic plc.
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Johnson & Johnson Services Inc.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Abbott Laboratories
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. Boston Scientific Corporation
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Olympus Corporation
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Stryker Corporation
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Smith & Nephew plc
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Varian Medical Systems Inc.
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. CONMED Corporation
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. AngioDynamics Inc.
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports